It has been reported that the RAS-RAF-MEK-ERK signal chain is an important signal transduction pathway in malignant tumors (35), and in 85% of cases of low-grade early bladder cancer, MAPK is activated by mutation of the tyrosine kinase signaling pathway or Ras pathway (36). This evidence concerns the gene MAP2K7 and cancer.